Published in
Wiley Open Access, Pharmacology Research and Perspectives, 1(6), p. e00380, 2018
DOI: 10.1002/prp2.380
Links
Tools
Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects
Journal article published in 2018 by
Jan Hillson,
Tim Mant,
Molly Rosano,
Carolyn Huntenburg,
Mehrshid Alai-Safar,
Siddhesh Darne,
Donna Palmer,
Borislava G. Pavlova,
Jennifer Doralt,
Russell Reeve,
Niti Goel 
,
Doris Weilert,
Paul W. Rhyne,
Kamali Chance,
John Caminis
and other authors.
,
Doris Weilert,
Paul W. Rhyne,
Kamali Chance,
John Caminis
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 